Protocadherin 7 is overexpressed in castration resistant pro…
Established
22
Citations50
Refs2019
Year
Search Works
Work Details
- DOI 10.1002/pros.23898
- PMID https://pubmed.ncbi.nlm.nih.gov/31449679
- OpenAlex ID W2970799097
- Type Article
- Language EN
- Published 26 Aug 2019
- Volume 79 (15)
- Pages 1739–1751
- Source The Prostate
- Publisher Wiley
- FWCI 2.57
- Countries 1
- Institutions 4
- Added 05 Sep 2019
- Updated 30 Oct 2026
External Links
MENU
0
Protocadherin 7 is overexpressed in castration resistant prostate cancer and promotes aberrant MEK and AKT signaling
Article 2019 EN
BACKGROUND: Castrate resistant prostate cancer (CRPC) accounts for almost all prostate cancer (PCa) deaths. Aberrant activation of ERK/MEK and PI3K/AKT signaling pathways plays an important role in subsets of patients with CRPC. The role of protocadherin 7 (PCDH7) in modulating these signaling pathways is investigated for the first time in PCa in the present investigation. METHODS: PCDH7 expressio…
22
Citations
50
References
3
Authors
2.57
FWCI
Citations by Year
Last 7 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
3 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Gauri Shishodia | Louisiana State University (US) Feist-Weiller Cancer Center (US) +1 | — |
| 2 | Sweaty Koul | Louisiana State University (US) Feist-Weiller Cancer Center (US) +1 | — |
| 3 | Hari K. Koul Corresponding | Louisiana State University (US) Overton Brooks VA Medical Cent… (US) +2 |
Related Works
10Data: OpenAlex